Vascular calcification: from pathophysiology to biomarkers.

[1]  H. Vali,et al.  Elastin Haploinsufficiency Impedes the Progression of Arterial Calcification in MGP‐Deficient Mice , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  D. Kiel,et al.  RANKL Inhibition With Denosumab Does Not Influence 3‐Year Progression of Aortic Calcification or Incidence of Adverse Cardiovascular Events in Postmenopausal Women With Osteoporosis and High Cardiovascular Risk , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  Z. Massy,et al.  Calcimimetics increase CaSR expression and reduce mineralization in vascular smooth muscle cells: mechanisms of action. , 2014, Cardiovascular research.

[4]  S. Menini,et al.  The galectin-3/RAGE dyad modulates vascular osteogenesis in atherosclerosis. , 2013, Cardiovascular research.

[5]  Yong Gu,et al.  Effect of serum FGF‐23, MGP and fetuin‐A on calcium‐phosphate metabolism in maintenance hemodialysis patients , 2013, Hemodialysis international. International Symposium on Home Hemodialysis.

[6]  C. Bondor,et al.  Bone metabolism regulators and arterial stiffness in postmenopausal women. , 2013, Maturitas.

[7]  A. Papavassiliou,et al.  Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease. , 2013, International journal of cardiology.

[8]  G. Blake,et al.  The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women. , 2013, Bone.

[9]  A. Berezin,et al.  Circulating osteopontin as a marker of early coronary vascular calcification in type two diabetes mellitus patients with known asymptomatic coronary artery disease. , 2013, Atherosclerosis.

[10]  R. Villa-Bellosta,et al.  Prevention of vascular calcification by polyphosphates and nucleotides- role of ATP. , 2013, Circulation journal : official journal of the Japanese Circulation Society.

[11]  D. Gordin,et al.  Osteoprotegerin is an independent predictor of vascular events in Finnish adults with type 1 diabetes. Diabetes Care 2013;36:1827–1833 , 2013, Diabetes Care.

[12]  H. Qiu,et al.  Osteoprotegerin Inhibits Calcification of Vascular Smooth Muscle Cell via Down Regulation of the Notch1-RBP-Jκ/Msx2 Signaling Pathway , 2013, PloS one.

[13]  Z. Massy,et al.  Vascular calcification , 2013, Current opinion in nephrology and hypertension.

[14]  Si-ming Guan,et al.  Effects of alendronate on the Notch1‑RBP‑Jκ signaling pathway in the osteogenic differentiation and mineralization of vascular smooth muscle cells. , 2013, Molecular medicine reports.

[15]  P. D’Haese,et al.  Sclerostin: Another vascular calcification inhibitor? , 2013, The Journal of clinical endocrinology and metabolism.

[16]  Merlin C. Thomas,et al.  Osteoprotegerin Is an Independent Predictor of Vascular Events in Finnish Adults With Type 1 Diabetes , 2013, Diabetes Care.

[17]  M. Rastaldi,et al.  Calcium and Osteoprotegerin Levels Predict the Progression of the Abdominal Aortic Calcifications After Kidney Transplantation , 2013, Transplantation.

[18]  R. Autschbach,et al.  Sclerostin as a potential novel biomarker for aortic valve calcification: an in-vivo and ex-vivo study. , 2013, The Journal of heart valve disease.

[19]  Edward R. Smith,et al.  Fetuin-A-Containing Calciprotein Particles Reduce Mineral Stress in the Macrophage , 2013, PloS one.

[20]  E. Schmidt,et al.  Osteoprotegerin and mortality in hemodialysis patients with cardiovascular disease. , 2013, Clinical nephrology.

[21]  J. Uitto,et al.  Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. , 2013, Trends in molecular medicine.

[22]  Shih‐Ping Hsu,et al.  Low serum fetuin A levels and incident stroke in patients with maintenance haemodialysis , 2013, European journal of clinical investigation.

[23]  R. Chapurlat,et al.  Lower fracture risk in older men with higher sclerostin concentration: A prospective analysis from the MINOS study , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  Chien-Te Lee,et al.  Biomarkers Associated with Vascular and Valvular Calcification in Chronic Hemodialysis Patients , 2013, Disease markers.

[25]  M. Kuro-o,et al.  Renal and extrarenal actions of Klotho. , 2013, Seminars in nephrology.

[26]  H. Xu,et al.  LRP5 and LRP6 in development and disease , 2013, Trends in Endocrinology & Metabolism.

[27]  M. Budoff,et al.  Fibroblast growth factor 23 is not associated with and does not induce arterial calcification , 2013, Kidney international.

[28]  S. Kanse,et al.  The Factor VII-activating Protease (FSAP) Enhances the Activity of Bone Morphogenetic Protein-2 (BMP-2)* , 2013, The Journal of Biological Chemistry.

[29]  M. Kawakami,et al.  Association of serum osteoprotegerin with vascular calcification in patients with type 2 diabetes , 2013, Cardiovascular Diabetology.

[30]  J. A. Garcia-Salcedo,et al.  Atherosclerotic Disease in Type 2 Diabetes Is Associated With an Increase in Sclerostin Levels , 2013, Diabetes Care.

[31]  M. Moroi,et al.  A preliminary study of the potential role of FGF-23 in coronary calcification in patients with suspected coronary artery disease. , 2013, Atherosclerosis.

[32]  Ali F. Abdel-Wahab,et al.  Negative correlation between fetuin-A and indices of vascular disease in systemic lupus erythematosus patients with and without lupus nephritis. , 2013, Arab journal of nephrology and transplantation.

[33]  J. M. Torres,et al.  Biochemical markers of vascular calcification in elderly hemodialysis patients , 2013, Molecular and Cellular Biochemistry.

[34]  J. Loscalzo,et al.  Bone Morphogenetic Protein‐2 Decreases MicroRNA‐30b and MicroRNA‐30c to Promote Vascular Smooth Muscle Cell Calcification , 2012, Journal of the American Heart Association.

[35]  J. Lekakis,et al.  Arterial stiffness and novel biomarkers in patients with abdominal aortic aneurysms , 2012, Regulatory Peptides.

[36]  S. Abbara,et al.  Receptor Activator of Nuclear Factor-&kgr;B Ligand (RANKL) and Its Relationship to Coronary Atherosclerosis in HIV Patients , 2012, Journal of acquired immune deficiency syndromes.

[37]  L. Rasmussen,et al.  No influence of OPG and its ligands, RANKL and TRAIL, on proliferation and regulation of the calcification process in primary human vascular smooth muscle cells , 2012, Molecular and Cellular Endocrinology.

[38]  S. Morony,et al.  Enhanced Mineralization Potential of Vascular Cells from SM22α-Rankltg Mice , 2012, Calcified Tissue International.

[39]  Dakang Xu,et al.  Osteopontin promotes inflammation in patients with acute coronary syndrome through its activity on IL‐17 producing cells , 2012, European journal of immunology.

[40]  Aortic Calcification and Bone Metabolism: The Relationship between Aortic Calcification, BMD, Vertebral Fracture, 25-Hydroxyvitamin D, and Osteocalcin , 2012, Calcified Tissue International.

[41]  M. Rosenfeld,et al.  RANKL Enhances Macrophage Paracrine Pro-Calcific Activity in High Phosphate-Treated Smooth Muscle Cells: Dependence on IL-6 and TNF-α , 2012, Journal of Vascular Research.

[42]  Marc M. Takeno,et al.  Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet , 2012, Kidney international.

[43]  P. Dechow,et al.  Repression of osteocyte Wnt/β‐catenin signaling is an early event in the progression of renal osteodystrophy , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[44]  L. Lerman,et al.  Osteocalcin positive CD133+/CD34-/KDR+ progenitor cells as an independent marker for unstable atherosclerosis. , 2012, European heart journal.

[45]  C. Shanahan,et al.  Calcium regulation of vascular smooth muscle cell-derived matrix vesicles. , 2012, Trends in cardiovascular medicine.

[46]  V. Perkovic,et al.  Phosphate in early chronic kidney disease: Associations with clinical outcomes and a target to reduce cardiovascular risk , 2012, Nephrology.

[47]  Zhenyu Tang,et al.  Differentiation of Multipotent Vascular Stem Cells Contributes to Vascular Diseases , 2012, Nature Communications.

[48]  Y. Caliskan,et al.  Osteoprotegerin/RANKL axis and progression of coronary artery calcification in hemodialysis patients. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[49]  W. März,et al.  Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[50]  Yuanhan Qin,et al.  Fibroblast Growth Factor-23 Helps Explain the Biphasic Cardiovascular Effects of Vitamin D in Chronic Kidney Disease , 2012, International journal of biological sciences.

[51]  I. Jaussent,et al.  Bone Biomarkers Help Grading Severity of Coronary Calcifications in Non Dialysis Chronic Kidney Disease Patients , 2012, PloS one.

[52]  E. McNally,et al.  Genetic pathways of vascular calcification. , 2012, Trends in cardiovascular medicine.

[53]  Edward R. Smith,et al.  Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[54]  A. Avogaro,et al.  Procalcific Phenotypic Drift of Circulating Progenitor Cells in Type 2 Diabetes with Coronary Artery Disease , 2012, Experimental diabetes research.

[55]  L. Hofbauer,et al.  Serum level of the phosphaturic factor FGF23 is associated with abdominal aortic calcification in men: the STRAMBO study. , 2012, The Journal of clinical endocrinology and metabolism.

[56]  K. Bornfeldt,et al.  S100A8 and S100A9 in cardiovascular biology and disease. , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[57]  A. Papavassiliou,et al.  Novel biomarkers assessing the calcium deposition in coronary artery disease. , 2012, Current medicinal chemistry.

[58]  E. Olson,et al.  Muscle : fundamental biology and mechanisms of disease , 2012 .

[59]  Z. Massy,et al.  FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages , 2012, Osteoporosis International.

[60]  Udo Hoffmann,et al.  Genome-Wide Association Study for Coronary Artery Calcification With Follow-Up in Myocardial Infarction , 2011, Circulation.

[61]  J. M. Torres,et al.  Mineral-bone metabolism markers in young hemodialysis patients. , 2011, Clinical biochemistry.

[62]  M. Budoff,et al.  Correlates of osteoprotegerin and association with aortic pulse wave velocity in patients with chronic kidney disease. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[63]  M. Chonchol,et al.  The role of phosphorus in the development and progression of vascular calcification. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[64]  A. Go,et al.  FGF23 induces left ventricular hypertrophy. , 2011, The Journal of clinical investigation.

[65]  Jeffrey A. White,et al.  Daily peritoneal administration of sodium pyrophosphate in a dialysis solution prevents the development of vascular calcification in a mouse model of uraemia. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[66]  C. Shanahan,et al.  Arterial Calcification in Chronic Kidney Disease: Key Roles for Calcium and Phosphate , 2011, Circulation research.

[67]  Y. Rais,et al.  Bone Gla Protein Increases HIF-1&agr;–Dependent Glucose Metabolism and Induces Cartilage and Vascular Calcification , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[68]  R. Terkeltaub,et al.  Genetics in Arterial Calcification: Pieces of a Puzzle and Cogs in a Wheel , 2011, Circulation research.

[69]  W. C. O'Neill,et al.  Matrix Gla Protein Metabolism in Vascular Smooth Muscle and Role in Uremic Vascular Calcification* , 2011, The Journal of Biological Chemistry.

[70]  J. Bacchetta,et al.  [FGF23 and Klotho: the new cornerstones of phosphate/calcium metabolism]. , 2011, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[71]  Jorge B Cannata-Andía,et al.  Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[72]  Y. Rais,et al.  Bone Gla Protein induces cartilage and vascular calcification via HIF1-α-dependent glucose metabolism , 2011 .

[73]  H. Jung,et al.  Fetuin-A, coronary artery calcification and outcome in maintenance hemodialysis patients. , 2011, Clinical nephrology.

[74]  G. Silvestrini,et al.  Peripheral artery calcifications evaluated by histology correlate to those detected by CT: relationships with fetuin-A and FGF-23. , 2011, Journal of nephrology.

[75]  M. Shearer,et al.  Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD). , 2011, Bone.

[76]  E. Coche,et al.  Serum fetuin-A levels are associated with vascular calcifications and predict cardiovascular events in renal transplant recipients. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[77]  W. C. O'Neill,et al.  Treatment with pyrophosphate inhibits uremic vascular calcification. , 2011, Kidney international.

[78]  L. Schurgers,et al.  Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD. , 2011, Journal of the American Society of Nephrology : JASN.

[79]  Florian Kronenberg,et al.  Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[80]  R. Villa-Bellosta,et al.  Calcium Phosphate Deposition With Normal Phosphate Concentration , 2011 .

[81]  J. Bacchetta,et al.  FGF 23 and Klotho : The new cornerstones of phosphate / calcium metabolism , 2011 .

[82]  R. Villa-Bellosta,et al.  Calcium phosphate deposition with normal phosphate concentration. -Role of pyrophosphate-. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[83]  M. D. de Broe.  Calcium regulates key components of vascular smooth muscle cell– derived matrix vesicles to enhance mineralization. , 2011, Kidney international.

[84]  J. Golledge,et al.  Osteo-progenitors in vascular calcification: a circulating cell theory. , 2011, Journal of atherosclerosis and thrombosis.

[85]  A. Schmidt,et al.  S100/calgranulins EN-RAGEing the blood vessels: implications for inflammatory responses and atherosclerosis. , 2011, American journal of cardiovascular disease.

[86]  C. Ahn,et al.  Factors associated with aortic stiffness and its change over time in peritoneal dialysis patients. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[87]  Takayuki Hamano,et al.  Fetuin-mineral complex reflects extraosseous calcification stress in CKD. , 2010, Journal of the American Society of Nephrology : JASN.

[88]  A. Kırkpantur,et al.  Plasma fibroblast growth factor‐23 levels are independently associated with carotid artery atherosclerosis in maintenance hemodialysis patients , 2010, Hemodialysis international. International Symposium on Home Hemodialysis.

[89]  Usama A A Sharaf El Din,et al.  Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[90]  L. Schurgers,et al.  The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study , 2010, Annals of Internal Medicine.

[91]  L. Schurgers,et al.  The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[92]  Brian J. Bennett,et al.  Inhibition of bone morphogenetic protein protects against atherosclerosis and vascular calcification , 2010, Circulation research.

[93]  L. Kenner,et al.  Neutralization of Osteopontin Inhibits Obesity-Induced Inflammation and Insulin Resistance , 2010, Diabetes.

[94]  Z. Massy,et al.  Calcium-sensing receptor as a potential modulator of vascular calcification in chronic kidney disease. , 2010, Journal of nephrology.

[95]  H. Ryoo,et al.  Tumor necrosis factor-alpha increases alkaline phosphatase expression in vascular smooth muscle cells via MSX2 induction. , 2010, Biochemical and biophysical research communications.

[96]  W. C. O'Neill,et al.  Plasma pyrophosphate and vascular calcification in chronic kidney disease. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[97]  Z. Dai,et al.  Intermittent high glucose enhances proliferation of vascular smooth muscle cells by upregulating osteopontin , 2009, Molecular and Cellular Endocrinology.

[98]  G. Werstuck,et al.  Effect of Leptin on Vascular Calcification in Apolipoprotein E–Deficient Mice , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[99]  D. Prié,et al.  Un nouveau système de régulation du bilan du phosphate : Fibroblast Growth Factor 23-Klotho , 2009 .

[100]  I. Jaussent,et al.  A cut-off value of plasma osteoprotegerin level may predict the presence of coronary artery calcifications in chronic kidney disease patients. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[101]  C. Chazot,et al.  High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[102]  P. Kostenuik,et al.  Inhibition of receptor activator of NF-kappaB ligand by denosumab attenuates vascular calcium deposition in mice. , 2009, The American journal of pathology.

[103]  A. Mann,et al.  Effect of osteocalcin deficiency on the nanomechanics and chemistry of mouse bones. , 2009, Journal of the mechanical behavior of biomedical materials.

[104]  Z. Massy,et al.  The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE-/-) mice. , 2009, Atherosclerosis.

[105]  D. Towler,et al.  Vascular calcification: the killer of patients with chronic kidney disease. , 2009, Journal of the American Society of Nephrology : JASN.

[106]  L. Ghiadoni,et al.  Osteopontin Is Associated with Increased Arterial Stiffness in Rheumatoid Arthritis , 2009, Molecular medicine.

[107]  M. Ketteler,et al.  Getting the balance right : Assessing causes and extent of vascular calcification in chronic kidney disease , 2009 .

[108]  C. Reutelingsperger,et al.  Fetuin-A protects against atherosclerotic calcification in CKD. , 2009, Journal of the American Society of Nephrology : JASN.

[109]  P. Price,et al.  Mineralization by Inhibitor Exclusion , 2009, The Journal of Biological Chemistry.

[110]  P. U. Ureña Torres,et al.  [Fibroblast Growth Factor 23-Klotho: a new axis of phosphate balance control]. , 2009, Medecine sciences : M/S.

[111]  W. C. O'Neill,et al.  Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure. , 2009, Kidney international.

[112]  Alberto Piazza,et al.  Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants , 2009, Nature Genetics.

[113]  T. Vizard,et al.  Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells. , 2009, Cardiovascular research.

[114]  A. Branscum,et al.  Low bone volume--a risk factor for coronary calcifications in hemodialysis patients. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[115]  A. Mahnken,et al.  Uncarboxylated matrix Gla protein (ucMGP) is associated with coronary artery calcification in haemodialysis patients , 2009, Thrombosis and Haemostasis.

[116]  C. Chazot,et al.  Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[117]  D. Prié,et al.  [Fibroblast Growth Factor 23-Klotho: a new axis of phosphate balance control]. , 2009, Medecine sciences : M/S.

[118]  D. Prié,et al.  [A new axis of phosphate balance control: fibroblast growth factor 23-Klotho]. , 2009, Nephrologie & therapeutique.

[119]  G. Coen.  Calcimimetics, parathyroid hormone, and vascular calcification in chronic kidney disease. , 2008, Kidney international.

[120]  G. London,et al.  Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. , 2008, Journal of the American Society of Nephrology : JASN.

[121]  Xianwu Li,et al.  BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. , 2008, Atherosclerosis.

[122]  Jun Li,et al.  Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study. , 2008, Human molecular genetics.

[123]  J. Kappes,et al.  Oxidative Stress Induces Vascular Calcification through Modulation of the Osteogenic Transcription Factor Runx2 by AKT Signaling* , 2008, Journal of Biological Chemistry.

[124]  Z. Massy,et al.  High extracellular inorganic phosphate concentration inhibits RANK–RANKL signaling in osteoclast‐like cells , 2008, Journal of cellular physiology.

[125]  Matthew R Allen,et al.  Mechanical Stimulation of Bone in Vivo Reduces Osteocyte Expression of Sost/Sclerostin* , 2008, Journal of Biological Chemistry.

[126]  P. Kostenuik,et al.  Osteoprotegerin Inhibits Vascular Calcification Without Affecting Atherosclerosis in ldlr(−/−) Mice , 2008, Circulation.

[127]  J. Cristol,et al.  Superoxide production: A procalcifying cell signalling event in osteoblastic differentiation of vascular smooth muscle cells exposed to calcification media , 2008, Free radical research.

[128]  J. Uitto,et al.  Pseudoxanthoma elasticum: reduced gamma-glutamyl carboxylation of matrix gla protein in a mouse model (Abcc6-/-). , 2007, Biochemical and biophysical research communications.

[129]  Timur Shtatland,et al.  Osteogenesis Associates With Inflammation in Early-Stage Atherosclerosis Evaluated by Molecular Imaging In Vivo , 2007, Circulation.

[130]  Koichi Matsumoto,et al.  Evaluation of serum fetuin-A relationships with biochemical parameters in patients on hemodialysis , 2007, Clinical and Experimental Nephrology.

[131]  C. Shanahan,et al.  Inflammation ushers in calcification: a cycle of damage and protection? , 2007, Circulation.

[132]  G. Simonetti,et al.  Are PTH serum levels predictive of coronary calcifications in haemodialysis patients? , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[133]  L. Liaw,et al.  Osteopontin: A Multifunctional Molecule Regulating Chronic Inflammation and Vascular Disease , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[134]  Jason R. Stubbs,et al.  Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice. , 2007, Journal of the American Society of Nephrology : JASN.

[135]  V. Jorgetti,et al.  Vascular calcification: contribution of parathyroid hormone in renal failure. , 2007, Kidney international.

[136]  L. Schurgers,et al.  Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. , 2007, Blood.

[137]  N. Chen,et al.  Fetuin-A uptake in bovine vascular smooth muscle cells is calcium dependent and mediated by annexins. , 2007, American journal of physiology. Renal physiology.

[138]  Brian J. Bennett,et al.  Osteoprotegerin Inactivation Accelerates Advanced Atherosclerotic Lesion Progression and Calcification in Older ApoE−/− Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[139]  M. Inaba,et al.  Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients , 2006, Osteoporosis International.

[140]  L. Matrisian,et al.  Matrix Metalloproteinase Inhibition Attenuates Aortic Calcification , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[141]  O. MacDougald,et al.  Regulation of bone mass by Wnt signaling. , 2006, The Journal of clinical investigation.

[142]  K. Leunissen,et al.  Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[143]  Xianwu Li,et al.  Role of the Sodium-Dependent Phosphate Cotransporter, Pit-1, in Vascular Smooth Muscle Cell Calcification , 2006, Circulation research.

[144]  I. Jaussent,et al.  Plasma osteoprotegerin is associated with mortality in hemodialysis patients. , 2005, Journal of the American Society of Nephrology : JASN.

[145]  J. Floege,et al.  Calcification and the usual suspect phosphate: still guilty but there are other guys behind the scenes. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[146]  J. Skepper,et al.  Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification. , 2005, Journal of the American Society of Nephrology : JASN.

[147]  J. Wildberger,et al.  Relation of oral anticoagulation to cardiac valvular and coronary calcium assessed by multislice spiral computed tomography. , 2005, The American journal of cardiology.

[148]  W. C. O'Neill,et al.  Reduced plasma pyrophosphate levels in hemodialysis patients. , 2005, Journal of the American Society of Nephrology : JASN.

[149]  C. Reutelingsperger,et al.  Novel Conformation-Specific Antibodies Against Matrix γ-Carboxyglutamic Acid (Gla) Protein: Undercarboxylated Matrix Gla Protein as Marker for Vascular Calcification , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[150]  N. Chen,et al.  Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). , 2005, Kidney international.

[151]  Su‐Li Cheng,et al.  Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. , 2005, The Journal of clinical investigation.

[152]  M. McKee,et al.  Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. , 2005, Genes & development.

[153]  Xianwu Li,et al.  Regulation of Vascular Calcification Roles of Phosphate and Osteopontin , 2005 .

[154]  V. Jorgetti,et al.  Coronary calcification in hemodialysis patients: the contribution of traditional and uremia-related risk factors. , 2005, Kidney international.

[155]  R. Terkeltaub,et al.  Chondrogenesis Mediated by PPi Depletion Promotes Spontaneous Aortic Calcification in NPP1−/− Mice , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[156]  D. Towler.  Inorganic pyrophosphate: a paracrine regulator of vascular calcification and smooth muscle phenotype. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[157]  C. Giachelli.  Vascular calcification mechanisms. , 2004, Journal of the American Society of Nephrology : JASN.

[158]  L. Schurgers,et al.  Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. , 2004, Journal of the American Society of Nephrology : JASN.

[159]  E. Ritz,et al.  Vascular calcification: a stiff challenge for the nephrologist: does preventing bone disease cause arterial disease? , 2004, Kidney international.

[160]  G. London,et al.  Arterial calcifications and bone histomorphometry in end-stage renal disease. , 2004, Journal of the American Society of Nephrology : JASN.

[161]  M. McKee,et al.  Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins , 2004, The Journal of cell biology.

[162]  R. Terkeltaub,et al.  Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders. , 2004, The American journal of pathology.

[163]  Su‐Li Cheng,et al.  Teriparatide (Human Parathyroid Hormone (1–34)) Inhibits Osteogenic Vascular Calcification in Diabetic Low Density Lipoprotein Receptor-deficient Mice* , 2003, Journal of Biological Chemistry.

[164]  C. Giachelli.  Vascular calcification: in vitro evidence for the role of inorganic phosphate. , 2003, Journal of the American Society of Nephrology : JASN.

[165]  R. Terkeltaub,et al.  Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification , 2003, Nature Genetics.

[166]  A. Schwarz,et al.  The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification , 2003 .

[167]  P. Price,et al.  The Inhibition of Calcium Phosphate Precipitation by Fetuin Is Accompanied by the Formation of a Fetuin-Mineral Complex* , 2003, Journal of Biological Chemistry.

[168]  T. Renné,et al.  Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. , 2003, The Journal of biological chemistry.

[169]  C. Wanner,et al.  Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study , 2003, The Lancet.

[170]  N. Chen,et al.  Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. , 2003, Kidney international.

[171]  Horst Seidler,et al.  The iceman: discovery and imaging. , 2003, Radiology.

[172]  A. Sweatt,et al.  Matrix Gla protein (MGP) and bone morphogenetic protein‐2 in aortic calcified lesions of aging rats , 2003, Journal of thrombosis and haemostasis : JTH.

[173]  R. Guldberg,et al.  Inactivation of the Osteopontin Gene Enhances Vascular Calcification of Matrix Gla Protein–deficient Mice , 2002, The Journal of experimental medicine.

[174]  P. Collin‐Osdoby,et al.  Basic Fibroblast Growth Factor Stimulates Osteoclast Recruitment, Development, and Bone Pit Resorption in Association With Angiogenesis In Vivo on the Chick Chorioallantoic Membrane and Activates Isolated Avian Osteoclast Resorption In Vitro , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[175]  M. Roy,et al.  Matrix Gla protein binding to hydroxyapatite is dependent on the ionic environment: calcium enhances binding affinity but phosphate and magnesium decrease affinity. , 2002, Bone.

[176]  T. Rajavashisth,et al.  Rationale for the role of osteoclast‐like cells in arterial calcification , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[177]  Patrick Royston,et al.  Autosomal Genome-Wide Scan for Coronary Artery Calcification Loci in Sibships at High Risk for Hypertension , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[178]  F. Parhami,et al.  Monocyte/Macrophage Regulation of Vascular Calcification In Vitro , 2002, Circulation.

[179]  Sharon M Moe,et al.  Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. , 2002, Kidney international.

[180]  R. Aebersold,et al.  Smooth Muscle Cell Phenotypic Transition Associated With Calcification: Upregulation of Cbfa1 and Downregulation of Smooth Muscle Lineage Markers , 2001, Circulation research.

[181]  S. Ganesh,et al.  Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. , 2001, Journal of the American Society of Nephrology : JASN.

[182]  J. Woo,et al.  Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. , 2001, Journal of the American Society of Nephrology : JASN.

[183]  F. Parhami,et al.  Leptin Enhances the Calcification of Vascular Cells: Artery Wall as a Target of Leptin , 2001, Circulation research.

[184]  G. Pharr,et al.  Correlations between osteocalcin content, degree of mineralization, and mechanical properties of C. carpio rib bone. , 2001, Journal of biomedical materials research.

[185]  D. Galas,et al.  Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. , 2001, American journal of human genetics.

[186]  M Dioszegi,et al.  Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). , 2001, Human molecular genetics.

[187]  D. Daret,et al.  Time Course of Osteopontin, Osteocalcin, and Osteonectin Accumulation and Calcification After Acute Vessel Wall Injury , 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[188]  J. Skepper,et al.  Apoptosis Regulates Human Vascular Calcification In Vitro: Evidence for Initiation of Vascular Calcification by Apoptotic Bodies , 2000, Circulation research.

[189]  F. Parhami,et al.  Tumor Necrosis Factor-&agr; Promotes In Vitro Calcification of Vascular Cells via the cAMP Pathway , 2000, Circulation.

[190]  M. McKee,et al.  Phosphate regulation of vascular smooth muscle cell calcification. , 2000, Circulation research.

[191]  C. Giachelli,et al.  Phosphorylation of Osteopontin Is Required for Inhibition of Vascular Smooth Muscle Cell Calcification* , 2000, The Journal of Biological Chemistry.

[192]  F. Port,et al.  Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[193]  R. Jilka,et al.  Essential Requirement of BMPs‐2/4 for Both Osteoblast and Osteoclast Formation in Murine Bone Marrow Cultures from Adult Mice: Antagonism by Noggin , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[194]  L. Demer,et al.  Regulatory mechanisms in vascular calcification. , 2000, Critical reviews in eukaryotic gene expression.

[195]  K. Mann,et al.  Noncollagenous bone matrix proteins, calcification, and thrombosis in carotid artery atherosclerosis. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[196]  M D McKee,et al.  Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin. , 1999, Circulation research.

[197]  P. Price,et al.  Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[198]  W. Jacob,et al.  Apoptosis and related proteins in different stages of human atherosclerotic plaques. , 1998, Circulation.

[199]  S. Morony,et al.  osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. , 1998, Genes & development.

[200]  D. Lacey,et al.  Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation , 1998, Cell.

[201]  R. Behringer,et al.  Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein , 1997, Nature.

[202]  Allan Bradley,et al.  Increased bone formation in osteocalcin-deficient mice , 1996, Nature.

[203]  P. Hauschka,et al.  Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. , 1996, The Biochemical journal.

[204]  E. Zeitler,et al.  Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[205]  Kim Km.  Apoptosis and calcification. , 1995 .

[206]  C. Alpers,et al.  Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. , 1993, The Journal of clinical investigation.

[207]  C McRae,et al.  Myocardial infarction. , 2019, Australian family physician.

[208]  Z. Massy,et al.  Hypertension in the Elderly , 1989 .

[209]  C. Vermeer,et al.  The effect of Gla-containing proteins on the precipitation of insoluble salts. , 1987, Biochemical and biophysical research communications.

[210]  F J Schoen,et al.  Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. , 1983, The American journal of pathology.

[211]  R. Levy,et al.  The identification of the vitamin K-dependent bone protein osteocalcin as one of the gamma-carboxyglutamic acid containing proteins present in calcified atherosclerotic plaque and mineralized heart valves. , 1983, Atherosclerosis.